4.1 Article

The Treatment of Retinoblastoma with Four-Drug Regimen Including Cisplatin, Etoposide, Vincristine, and Cyclophosphamide

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Management of high-risk retinoblastoma

Guillermo L. Chantada et al.

EXPERT REVIEW OF OPHTHALMOLOGY (2012)

Article Oncology

Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma

Peter E. Zage et al.

PEDIATRIC BLOOD & CANCER (2008)

Article Oncology

Conservative therapy in intraocular retinoblastoma - Response/recurrence rate

A Schiavetti et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)

Article Ophthalmology

Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.

CL Shields et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)

Article Ophthalmology

A multicentre report from the Mexican retinoblastoma group

C Leal-Leal et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2004)

Article Ophthalmology

Continuing challenges in the management of retinoblastoma with chemotherapy

CL Shields et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2004)

Article Ophthalmology

Practical approach to management of retinoblastoma

CL Shields et al.

ARCHIVES OF OPHTHALMOLOGY (2004)

Article Ophthalmology

Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy

DA Sussman et al.

ARCHIVES OF OPHTHALMOLOGY (2003)

Article Oncology

Treatment of intraocular retinoblastoma with vincristine and carboplatin

C Rodriguez-Galindo et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Oncology

Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma

DL Friedman et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)